 Connection
Viralkumar Shah to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications Viralkumar Shah has written about Diabetes Mellitus, Type 2.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
4.028 |
|
|
|
-
Shah VN, Dex T, Meneghini L, Rodrigues A, Polonsky WH. Treatment satisfaction and time in range after 16?weeks of treatment with iGlarLixi in insulin-naive adults with suboptimally controlled type 2 diabetes. Diabetes Obes Metab. 2025 May; 27(5):2523-2530.
Score: 0.339
-
Fr?as JP, Ratzki-Leewing A, Dex T, Meneghini L, Rodrigues A, Shah VN. Effect of iGlarLixi on continuous glucose monitoring-measured time in range in insulin-naive adults with suboptimally controlled type 2 diabetes. Diabetes Obes Metab. 2025 Apr; 27(4):2173-2182.
Score: 0.338
-
Shah VN, Leslie WD, Lautatzis ME, Liu K, Prior HJ, Wicklow B. Maternal diabetes and fracture risk in offspring: a population-based analysis. J Bone Miner Res. 2024 Jul 23; 39(6):683-687.
Score: 0.326
-
Shah VN, Prattichizzo F, Ceriello A. Obesity and Diabetes. Diabetes Technol Ther. 2023 02; 25(S1):S217-S226.
Score: 0.294
-
Akturk HK, Shah VN. Gastric Emptying Abnormalities in Diabetes Mellitus. N Engl J Med. 2021 08 05; 385(6):575-576.
Score: 0.265
-
Jackson MA, Ahmann A, Shah VN. Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring. Diabetes Technol Ther. 2021 03; 23(S1):S27-S34.
Score: 0.257
-
Shah VN. Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment. N Engl J Med. 2021 02 25; 384(8):e26.
Score: 0.257
-
Sherk VD, Schauer I, Shah VN. Update on the Acute Effects of Glucose, Insulin, and Incretins on Bone Turnover In Vivo. Curr Osteoporos Rep. 2020 08; 18(4):371-377.
Score: 0.247
-
Garg SK, Wernicke-Panten K, Wardecki M, Kramer D, Delalande F, Franek E, Sadeharju K, Monchamp T, Miossec P, Mukherjee B, Shah VN. Safety, Immunogenicity, and Glycemic Control of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People with Diabetes Also Using Insulin Glargine: 12-Month Results from the GEMELLI 1 Trial. Diabetes Technol Ther. 2020 07; 22(7):516-526.
Score: 0.241
-
Garg SK, Wernicke-Panten K, Wardecki M, Kramer D, Delalande F, Franek E, Sadeharju K, Monchamp T, Mukherjee B, Shah VN. Efficacy and Safety of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People with Diabetes Treated for 26 Weeks with Multiple Daily Injections in Combination with Insulin Glargine: A Randomized Open-Label Trial (GEMELLI 1). Diabetes Technol Ther. 2020 02; 22(2):85-95.
Score: 0.239
-
Shah VN, Laffel LM, Wadwa RP, Garg SK. Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator. Diabetes Technol Ther. 2018 06; 20(6):428-433.
Score: 0.213
-
Garg SK, Giordano D, Gallo T, Shah VN. New Medications for the Treatment of Diabetes. Diabetes Technol Ther. 2017 02; 19(S1):S128-S140.
Score: 0.194
-
Shah VN, Mohan V. Diabetes in India: what is different? Curr Opin Endocrinol Diabetes Obes. 2015 Aug; 22(4):283-9.
Score: 0.175
-
Shah VN, Yu L. Comment on Liu et al. Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3). Diabetes Care 2015;38:16-21. Diabetes Care. 2015 Mar; 38(3):e43.
Score: 0.170
-
Platnick C, Choi YJ, Narongkiatikhun P, Bekelman N, Rountree-Jablin C, Birznieks C, Sell E, Tommerdahl KL, de Boer I, Shah VN, Nadeau KJ, Sawyer A, Pyle L, Bjornstad P. Relationships among biological sex, body composition, and bone mineral density in young persons with and without diabetes. J Pediatr Endocrinol Metab. 2025 May 26; 38(5):476-487.
Score: 0.086
-
Pasquel FJ, Davis GM, Huffman DM, Peters AL, Parker JC, Laffel LM, Romeo GR, Mathew J, Castorino KN, Kruger DF, Dungan KM, Kipnes M, Jauch EC, Oser TK, Shah VN, Horowitz B, Carlson AL, Warren ML, Deeb W, Buse JB, Reed JH, Berner J, Blevins T, Bajaj C, Kollman C, Raghinaru D, Ly TT, Beck RW. Automated Insulin Delivery in Adults With Type 2 Diabetes: A Nonrandomized Clinical Trial. JAMA Netw Open. 2025 02 03; 8(2):e2459348.
Score: 0.084
-
Yeung AM, Huang J, Pandey A, Hashim IA, Kerr D, Pop-Busui R, Rhee CM, Shah VN, Bally L, Bayes-Genis A, Bee YM, Bergenstal R, Butler J, Fleming GA, Gilbert G, Greene SJ, Kosiborod MN, Leiter LA, Mankovsky B, Martens TW, Mathieu C, Mohan V, Patel KV, Peters A, Rhee EJ, Rosano GMC, Sacks DB, Sandoval Y, Seley JJ, Schnell O, Umpierrez G, Waki K, Wright EE, Wu AHB, Klonoff DC. Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society. Prog Cardiovasc Dis. 2023 Jul-Aug; 79:65-79.
Score: 0.075
-
Garg SK, Rodriguez E, Shah VN, Hirsch IB. New Medications for the Treatment of Diabetes. Diabetes Technol Ther. 2022 03; 24(S1):S190-S208.
Score: 0.069
-
Eckert AJ, Mader JK, Altmeier M, M?hldorfer S, Gillessen A, Dallmeier D, Shah VN, Heyer C, Hartmann B, Holl RW. Fracture risk in patients with type 2 diabetes aged =50?years related to HbA1c, acute complications, BMI and SGLT2i-use in the DPV registry. J Diabetes Complications. 2020 10; 34(10):107664.
Score: 0.061
-
Wadwa RP, Laffel LM, Shah VN, Garg SK. Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes. Diabetes Technol Ther. 2018 06; 20(6):395-402.
Score: 0.053
-
Gupta N, Bhadada SK, Shah VN, Mattoo SK. Psychological Aspects Related to Diabetes Mellitus. J Diabetes Res. 2016; 2016:7276403.
Score: 0.045
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|